Navigation Links
AST Concerned That Kidney Transplant Patients May Suffer Politics As Usual in Capitol Hill Health Care Reform Debate
Date:12/15/2009

WASHINGTON, Dec. 15 /PRNewswire-USNewswire/ -- Today's New York Times article by Kevin Sack, "Plan for Kidney Drugs Spurs Division," illustrates an internal renal community reimbursement debate that may result in kidney patients continuing to be deprived of their life-saving immunosuppressive medications beyond the current 36-month Medicare program limit.

As Congress is poised to approve this urgent transplant patient coverage to preserve the lives of transplant kidney recipients, behind-the-scenes debate continues within the renal community regarding how dialysis should be reimbursed. The American Society of Transplantation (AST) believes strongly that dialysis reimbursement, while important, should not hold hostage a bill that would provide thousands of kidney transplant patients their desperately needed and life-saving immunosuppressant medications.

AST President, Dr. Joren Madsen, stated this morning, "I applaud the New York Times for drawing attention to an urgent patient care issue which should not fall victim to politics as usual." Transplant patient immunosuppressive drug coverage has been AST's #1 Public Policy Issue for more than a decade. As this morning's New York Times article states, "It is pound foolish" to pay for a patient's organ transplant and then only give them a 36-month supply of the drugs they need to maintain their life-saving donor organ for the remainder of their life.

About AST

The American Society of Transplantation is an international organization of transplant professionals dedicated to advancing the field of transplantation through the promotion of research, education, advocacy, and organ donation to improve patient care. The Society comprises more than 3,100 transplant physicians, surgeons and allied health professionals.

For information about AST, visit www.a-s-t.org.


    CONTACT: Beth Drost at 215.884.6499
    beth@comsolutionsgroup.com

SOURCE The American Society of Transplantation


'/>"/>
SOURCE The American Society of Transplantation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. ACC Concerned Over Reporting of Biomonitoring Results
2. Methodist Dallas Medical Center First in Metroplex to Perform Kidney Transplant on HIV Positive Patient
3. FDA: Byetta Label Revised to Include Safety Information on Possible Kidney Problems
4. Quark Pharmaceuticals to Present Data on its siRNA Therapeutic Programs in Kidney and Lung Diseases
5. FDA Approves New Treatment for Advanced Form of Kidney Cancer
6. Satellite Healthcare Tees Up With the National Kidney Foundation in Santa Cruz, CA
7. Study Suggests that NGAL Identifies Acute Kidney Injury Early in ICU Patients
8. Bayers Novel Anti-Cancer Compound Regorafenib (BAY 73-4506) Showed Stabilization or Regression in 81 Percent of Kidney Cancer Patients
9. Keryx Biopharmaceuticals Phase 2 Data of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Renal Cell Cancer Selected for Oral Presentation at the Eighth International Kidney Cancer Symposium
10. WORLDS First Robotic Assisted Kidney Transplant Performed at Saint Barnabas Medical Center
11. Living Donor Kidney Transplants Using Alemtuzumab Pre-Conditioning and Tacrolimus Monotherapy: Long-Term Safety and Efficacy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... -- AllianceRx Walgreens Prime, the combined central specialty pharmacy and ... manager Prime Therapeutics LLC (Prime), today officially began the ... of new signage at its headquarters in ... few other company-owned facilities across the country. This also ... whom will begin to see the AllianceRx Walgreens Prime ...
(Date:9/27/2017)... -- Commended for their devotion to personalized service, SMP Pharmacy Solutions ... in the South Florida Business Journal,s 50 Fastest-Growing Companies, and ... the national specialty pharmacy has found its niche.  To that ... be honored by SFBJ as the 2017 Power Leader in ... receive his award in October, Bardisa said of the three ...
(Date:9/22/2017)... -- As the latest Obamacare repeal effort moves is debated, ... and Lindsey Graham (R-SC) medical device market ... is in an odd place.  The industry wants repeal ... on medical device sales passed along with the Affordable ... visits and hospital customers with the funding to invest ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to the ... save lost souls in the Philippines. “The Journey: From the Mountains to the Mission ... of the Bible. She has taught all ages and currently teaches a class of ...
(Date:10/12/2017)... ... 12, 2017 , ... CitiDent and San Francisco dentists, Dr. ... Oventus O2Vent technology. As many as 18 million Americans are estimated to suffer ... Oral appliances can offer significant relief to about 75 percent of people with ...
(Date:10/12/2017)... ... , ... IsoComforter, Inc. ( https://isocomforter.com ), one of the Nation’s ... design of the shoulder pad. The shoulder pad provides optimal support and full ... while using cold therapy. By utilizing ice and water that is circulated from an ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s National ... 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. ... for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., ...
Breaking Medicine News(10 mins):